Literature DB >> 24634547

Automated Multistep Continuous Flow Synthesis of 2-(1H-Indol-3-yl)thiazole Derivatives.

Nicholas Pagano1, Marintha L Heil2, Nicholas D P Cosford1.   

Abstract

The multistep continuous flow assembly of 2-(1H-indol-3-yl)thiazoles using a Syrris AFRICA® synthesis station is reported. Sequential Hantzsch thiazole synthesis, deketalization and Fischer indole synthesis provides rapid and efficient access to highly functionalized, pharmacologically significant 2-(1H-indol-3-yl)thiazoles. These complex, drug-like small molecules are generated in reaction times of less than 15 min and in high yields (38%-82% over three chemical steps without isolation of intermediates).

Entities:  

Keywords:  condensation; heterocycles; indoles; microfluidic synthesis; microreactors; tandem reaction

Year:  2012        PMID: 24634547      PMCID: PMC3953499          DOI: 10.1055/s-0031-1290953

Source DB:  PubMed          Journal:  Synthesis (Stuttg)        ISSN: 0039-7881            Impact factor:   3.157


  19 in total

1.  Continuous flow organic synthesis under high-temperature/pressure conditions.

Authors:  Tahseen Razzaq; C Oliver Kappe
Journal:  Chem Asian J       Date:  2010-06-01

2.  Continuous flow thermolysis of azidoacrylates for the synthesis of heterocycles and pharmaceutical intermediates.

Authors:  Alexander G O'Brien; François Lévesque; Peter H Seeberger
Journal:  Chem Commun (Camb)       Date:  2010-12-20       Impact factor: 6.222

Review 3.  Continuous flow microreactors for drug discovery.

Authors:  Paul Watts
Journal:  Curr Opin Drug Discov Devel       Date:  2004-11

Review 4.  Microwave reactions under continuous flow conditions.

Authors:  Ian R Baxendale; John J Hayward; Steven V Ley
Journal:  Comb Chem High Throughput Screen       Date:  2007-12       Impact factor: 1.339

Review 5.  Microfluidics for drug discovery and development: from target selection to product lifecycle management.

Authors:  Lifeng Kang; Bong Geun Chung; Robert Langer; Ali Khademhosseini
Journal:  Drug Discov Today       Date:  2007-11-26       Impact factor: 7.851

6.  Teubrevin G and teubrevin H: the first total syntheses of rearranged neo-clerodanes including solutions to the problems of chirality merger and furan ring assembly.

Authors:  L A Paquette; I Efremov
Journal:  J Am Chem Soc       Date:  2001-05-16       Impact factor: 15.419

7.  Synthesis and cytotoxic activity of indolyl thiazoles.

Authors:  C J Moody; J R Roffey; M A Stephens; I J Stratford
Journal:  Anticancer Drugs       Date:  1997-06       Impact factor: 2.248

8.  Rapid multistep synthesis of 1,2,4-oxadiazoles in a single continuous microreactor sequence.

Authors:  Daniel Grant; Russell Dahl; Nicholas D P Cosford
Journal:  J Org Chem       Date:  2008-08-08       Impact factor: 4.354

9.  Fully automated continuous flow synthesis of highly functionalized imidazo[1,2-a] heterocycles.

Authors:  Ananda Herath; Russell Dahl; Nicholas D P Cosford
Journal:  Org Lett       Date:  2010-02-05       Impact factor: 6.005

10.  Synthesis and biological activity of thiazolylindolequinones, analogues of the natural product BE 10988.

Authors:  C J Moody; E Swann; S Houlbrook; M A Stephens; I J Stratford
Journal:  J Med Chem       Date:  1995-03-17       Impact factor: 7.446

View more
  3 in total

1.  An integrated chemical biology approach reveals the mechanism of action of HIV replication inhibitors.

Authors:  Nicholas Pagano; Peter Teriete; Margrith E Mattmann; Li Yang; Beth A Snyder; Zhaohui Cai; Marintha L Heil; Nicholas D P Cosford
Journal:  Bioorg Med Chem       Date:  2017-04-08       Impact factor: 3.641

2.  A Combination of Flow and Batch Mode Processes for the Efficient Preparation of mGlu2/3 Receptor Negative Allosteric Modulators (NAMs).

Authors:  Raveendra Panickar Dhanya; Ananda Herath; Douglas J Sheffler; Nicholas D P Cosford
Journal:  Tetrahedron       Date:  2018-03-30       Impact factor: 2.457

Review 3.  Microfluidics for synthesis of peptide-based PET tracers.

Authors:  Yang Liu; Mei Tian; Hong Zhang
Journal:  Biomed Res Int       Date:  2013-10-31       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.